Compare CVS Health Corp (CVS) vs Huntington Bancshares Incorporated (HBAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Huntington Bancshares Incorporated — how do they compare? CVS Health Corp trades at $85.46 (market cap $112.29B), while Huntington Bancshares Incorporated trades at $15.41 (market cap $31.04B). The key difference: CVS Health Corp is far larger — about 3.6× Huntington Bancshares Incorporated's market cap, and Huntington Bancshares Incorporated pays the higher dividend (4.04%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Huntington Bancshares Incorporated for 52 Days on average.
| CVS | HBAN | |
|---|---|---|
Market Cap | $112.29B | $31.04B |
Volume | 7,763,676 | 23,864,172 |
Sector | Health | Financials |
52-Week High | $110.60 | $19.27 |
52-Week Low | $70.08 | $15.02 |
Typical Hold Time | 83 Days | 52 Days |
Enterprise Value | $174.64B | $49.57B |
Dividend Yield | 3.03% | 4.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
Huntington Bancshares (HBAN) trades at $15.17, down 1.04% on the day, reflecting recent pressure from margin headwinds and a lowered 2027 earnings outlook. The stock shows a bearish technical signal with moving averages indicating selling pressure, while fundamentals reveal a P/E of 11.67 and net income margin of 24.77%. Recent news highlights increased options activity and a new $0.16 dividend declaration, but investor sentiment is cautious amid interest rate challenges.
HBAN presents a mixed outlook with a consensus price target of $19.60 suggesting 29% upside, supported by shareholder returns via buybacks and dividends. However, risks include persistent net interest margin compression, competitive lending pressures, and macroeconomic sensitivity. The stock's valuation appears reasonable, but earnings misses and guidance cuts warrant close monitoring of upcoming Q3 2026 results for directional clarity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Huntington Bancshares Incorporated
Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.
Read more on HBAN →
